Loading company…
Valo Therapeutics, based in Helsinki, develops immunotherapies for cancer treatment and prevention.
Founded in 2016 in Helsinki, Finland, Valo Therapeutics Ltd. develops immunotherapies that use oncolytic and non-replicating vectors combined with disease-specific peptides. Revenue comes mainly from multi-year partnerships with pharmaceutical companies. On March 10, 2025, the company raised EUR 6 million in venture funding led by Freeman Road, bringing its total to EUR 13 million. The company has completed 7 deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in